Duchenne-izomdisztrófia: vizsgálatok itt: Kanada

5 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping

  Where

  London

  Életkor

  7 év to 16 év

  People

  70 worldwide

  Run by

  Avidity Biosciences, Inc.

  See details and how to joinNCT07587242
• 3. fázisTaking people
  A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

  Where

  Calgary, Toronto, Vancouver

  Életkor

  7 év to 11 év

  People

  80 worldwide

  Run by

  Solid Biosciences Inc.

  See details and how to joinNCT07160634 · EU 2025-522949-22-00
• 3. fázisTaking people
  Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy

  Where

  London, Ottawa, Toronto, Vancouver

  Életkor

  9 év to 17 év

  People

  138 worldwide

  Run by

  Italfarmaco

  See details and how to joinNCT05933057 · EU 2023-503521-19-00
• 1/2. fázisTaking people
  A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)

  Where

  Toronto

  Életkor

  0 év to 17 év

  People

  60 worldwide

  Run by

  Solid Biosciences Inc.

  See details and how to joinNCT06138639 · EU 2024-514501-57-00
• 2/3. fázisTaking people
  Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study

  Where

  Calgary, Toronto, Vancouver

  Életkor

  7 év and over

  People

  206 worldwide

  Run by

  Italfarmaco

  See details and how to joinNCT03373968